Human stanniocalcin-1 in venous blood of renal cell carcinoma patients

LUO Jun,LIU Min,CHE Jianping,XU Yunfei,PENG Bo,ZHENG Junhua

2013-01-01

Abstract:Objective To explore the expression of human stanniocalcin-1(hSTC-1)in venous blood of patients with renal cell carcinoma and its relationship with tumor grade,so as to provide a novel tumor marker for the diagnosis of renal cell carcinoma.Methods The expression of hSTC-1mRNA in venous blood of 25patients with renal cell carcinoma and 25people without tumor(including 5pregnant women)was determined by reverse transcription polymerase chain reaction(RT-PCR).The results were compared with clinical pathological data.Comprehensive evaluation of sensitivity and specificity was conducted by receiver operating characteristic(ROC) curve.Results Among the 25patients with renal cell carcinoma,14(56%)showed positive expression of hSTC-1.There was no significant difference in hSTC-1 mRNA expression among different genders,ages or pathological types(all P>0.05),while there was statistical difference in hSTC-1mRNA expression between stageⅠ-Ⅱ and stageⅢ-Ⅳ of renal cell carcinoma(P=0.007),and between the patients with and without distant lymph node metastasis(P=0.042).hSTC-1was not found in the venousl blood of people without tumor.ROC area under curve was 0.784,and 95% confidence interval was 0.646-0.914(P<0.01).Conclusion The mRNA level of hSTC-1in venous blood has a high diagnostic value for renal cell carcinoma.It may be a novel tumor marker for diagnosis and staging of renal cell carcinoma.